Effect of Ranitidine on Hyper-IgE Recurrent Infection (Job's) Syndrome

Stopped Failure to enroll adequate patient numbers due to small number of eligible patients

Conditions

• JOB's Syndrome
• Hyper-IgE Recurrent Infection Syndrome
• Immune Deficiency

Interventions

• DRUG: Ranitidine
• DRUG: Placebo

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)